Characterization of autostimulatory and transforming growth factors from human melanoma cells
- PMID: 3864531
Characterization of autostimulatory and transforming growth factors from human melanoma cells
Abstract
Serum-free growth of the human malignant melanoma cell line Hs0294 is associated with production of transforming growth factor-alpha and an autostimulatory melanoma mitogen (melanoma growth-stimulatory activity, MGSA). The transforming activity is characterized by stimulation of anchorage-independent growth of normal rat kidney fibroblasts and competition with 125I-epidermal growth factor for binding to normal rat kidney cells. The second activity, MGSA, stimulates the anchorage-dependent growth of human melanoma cells in serum-free culture medium. When acetic acid extracts of Hs0294 conditioned medium are subjected to Bio-Gel P-30 chromatography followed by reverse-phase high-pressure liquid chromatography, the majority of the transforming growth factor-alpha elutes at 30 +/- 4% acetonitrile, while the major peak of MGSA elutes at 35 +/- 3% acetonitrile. These data indicate that the anchorage-dependent serum-free growth of the Hs0294 human melanoma cell line is apparently dependent upon the autostimulatory melanoma mitogen, MGSA, which is separable from the 125I-epidermal growth factor competing activity produced by these cells.
Similar articles
-
Purification of melanoma growth stimulatory activity.J Cell Physiol. 1986 Dec;129(3):375-84. doi: 10.1002/jcp.1041290316. J Cell Physiol. 1986. PMID: 3465735
-
Preparation of a monoclonal antibody to a melanoma growth-stimulatory activity released into serum-free culture medium by Hs0294 malignant melanoma cells.J Cell Biochem. 1987 Jul;34(3):169-85. doi: 10.1002/jcb.240340304. J Cell Biochem. 1987. PMID: 3611199
-
Extraction of a melanoma growth-stimulatory activity from culture medium conditioned by the Hs0294 human melanoma cell line.Cancer Res. 1983 May;43(5):2106-12. Cancer Res. 1983. PMID: 6600964
-
Autocrine and paracrine roles for growth factors in melanoma.In Vivo. 1994 Jan-Feb;8(1):113-23. In Vivo. 1994. PMID: 7519892 Review.
-
The pathogenic role of growth factors in melanoma.Semin Dermatol. 1991 Sep;10(3):246-55. Semin Dermatol. 1991. PMID: 1931574 Review.
Cited by
-
Growth control of A431 cells in protein-free medium: secretory products do not affect cell growth.In Vitro Cell Dev Biol. 1988 Sep;24(9):893-9. doi: 10.1007/BF02623899. In Vitro Cell Dev Biol. 1988. PMID: 3170446
-
CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer.J Exp Med. 2006 Apr 17;203(4):941-51. doi: 10.1084/jem.20052124. Epub 2006 Mar 27. J Exp Med. 2006. PMID: 16567391 Free PMC article.
-
The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target.Cancers (Basel). 2025 May 15;17(10):1674. doi: 10.3390/cancers17101674. Cancers (Basel). 2025. PMID: 40427171 Free PMC article. Review.
-
Growth factor and growth factor receptor in radiation carcinogenesis.Radiat Environ Biophys. 1991;30(3):191-4. doi: 10.1007/BF01226616. Radiat Environ Biophys. 1991. PMID: 1924704 Review. No abstract available.
-
Broad targeting of resistance to apoptosis in cancer.Semin Cancer Biol. 2015 Dec;35 Suppl(0):S78-S103. doi: 10.1016/j.semcancer.2015.03.001. Epub 2015 Apr 28. Semin Cancer Biol. 2015. PMID: 25936818 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical